Marketing-authorisation holder · Canada
Alcon Canada Inc
79 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Canada
79 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 79
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ALCAINE0.5 % / w/v · Drops | Proxymetacaine | Canada | Marketed | 1971 |
| ALCON ATROPINE1 % / w/v · Solution | Atropine | Canada | Marketed | 1964 |
| ALCON TEARS 0.5%0.5 % / w/v · Solution | Hypromellose | Canada | Marketed | 1969 |
| ALCON TEARS 1%1 % / w/v · Solution | Hypromellose | Canada | Marketed | 1970 |
| BSS PLUS0.0154 % + 0.092 % + 0.0184 % + 0.02 % + 0.038 % + 0.21 % + 0.714 % + 0.042 % · Kit, Solution | Calcium chloride, Dextrose, Glutathione disulfide, Magnesium chloride, Potassium chloride, Bicarbonate, Sodium chloride, Dibasic | Canada | Marketed | 1982 |
| BSS STERILE IRRIGATING SOLUTION0.048 % + 0.03 % + 0.075 % + 0.39 % + 0.64 % + 0.17 % · Solution | Calcium chloride, Magnesium chloride, Potassium chloride, Sodium acetate trihydrate, Sodium chloride, Sodium citrate dihydrate | Canada | Marketed | 1980 |
| CYCLOGYL1 % / w/v · Drops | Cyclopentolate | Canada | Marketed | 1972 |
| FLUORESCITE10 % / w/v · Solution | Fluorescein | Canada | Marketed | 1980 |
| MIOSTAT OPHTHALMIC LIQ 0.01%0.01 % · Solution | Carbachol | Canada | Marketed | 1980 |
| MYDFRIN2.5 % / w/v · Solution | Phenylephrine | Canada | Marketed | 1979 |
| MYDRIACYL0.5 % / w/v · Solution | Tropicamide | Canada | Marketed | 1951 |
| MYDRIACYL1 % / w/v · Solution | Tropicamide | Canada | Marketed | 1969 |
| NAPHCON A0.025 % + 0.3 % · Solution | Naphazoline, Pheniramine | Canada | Marketed | 1980 |
| TEARS NATURALE FORTE0.1 % + 0.2 % + 0.3 % · Solution | Dextran, Glycerine, Hypromellose | Canada | Marketed | 2003 |
| TEARS NATURALE FREE0.1 % / w/v + 0.3 % / w/v · Drops | Dextran, Hypromellose | Canada | Marketed | 1992 |
| TEARS NATURALE II0.1 % / w/v + 0.3 % / w/v · Drops | Dextran, Hypromellose | Canada | Marketed | 1989 |
| ALCOMICIN OPH SOL 3MG/ML3 mg / ml · Liquid | Gentamicin | Canada | Cancelled | 1983 |
| ALLERGY EYE DROPS0.05 % + 0.25 % · Drops | Tetryzoline, Zinc | Canada | Cancelled | 2005 |
| AOSEPT SOLUTION 3%3 % · Solution | Hydrogen peroxide | Canada | Cancelled | 1992 |
| ARTIFICIAL TEARS0.1 % + 0.3 % · Solution | Dextran, Hypromellose | Canada | Cancelled | 2005 |
| ATROPINE ONT 1%1 % · Ointment | Atropine | Canada | Cancelled | 1972 |
| BETOPTIC LIQ0.5 % · Liquid | Betaxolol | Canada | Cancelled | 1986 |
| BETOPTIC/PILO0.25 % + 1.75 % · Suspension | Betaxolol, Pilocarpine | Canada | Cancelled | |
| BION TEARS - LIQ OPH0.1 % + 0.3 % · Drops | Dextran, Hypromellose | Canada | Cancelled | 1996 |
| BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION 0.2%0.2 % · Solution | Brimonidine | Canada | Cancelled |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 79 | 16 | 63 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.